These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31356559)
21. Nutritional consequences of long-term acid suppression; are they clinically important? Johnson DA Curr Opin Gastroenterol; 2016 Mar; 32(2):136-40. PubMed ID: 26760397 [TBL] [Abstract][Full Text] [Related]
22. Deprescribing proton pump inhibitors: why, when and how. Bytzer P Med J Aust; 2018 Nov; 209(10):436-438. PubMed ID: 30404592 [No Abstract] [Full Text] [Related]
23. [Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit]. Dipanda M; Pioro L; Buttard M; d'Athis P; Asgassou S; Putot S; Deïdda M; Laborde C; Putot A; Manckoundia P Therapie; 2017 Dec; 72(6):669-675. PubMed ID: 28939010 [TBL] [Abstract][Full Text] [Related]
24. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Freedberg DE; Kim LS; Yang YX Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716 [TBL] [Abstract][Full Text] [Related]
25. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence. Solem C; Mody R; Stephens J; Macahilig C; Gao X J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930 [TBL] [Abstract][Full Text] [Related]
26. Proton Pump Inhibitor Prescribing and Monitoring Patterns Among Gastroenterology Practitioners. Leiman DA; Ravi K; Freedberg DE; Gyawali CP J Clin Gastroenterol; 2022 Aug; 56(7):571-575. PubMed ID: 34608025 [TBL] [Abstract][Full Text] [Related]
27. Toxicity of long-term use of proton pump inhibitors in children. De Bruyne P; Ito S Arch Dis Child; 2018 Jan; 103(1):78-82. PubMed ID: 29237614 [TBL] [Abstract][Full Text] [Related]
28. When is proton pump inhibitor use appropriate? Yadlapati R; Kahrilas PJ BMC Med; 2017 Feb; 15(1):36. PubMed ID: 28219434 [TBL] [Abstract][Full Text] [Related]
29. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital. Luo H; Fan Q; Xiao S; Chen K BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830 [TBL] [Abstract][Full Text] [Related]
30. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties. Luetzenberg FS; Jiang N Laryngoscope; 2020 Feb; 130(2):321-327. PubMed ID: 30861137 [TBL] [Abstract][Full Text] [Related]
31. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms. Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725 [TBL] [Abstract][Full Text] [Related]
32. Proton pump inhibitors: the good, the bad, and the unwanted. Chubineh S; Birk J South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806 [TBL] [Abstract][Full Text] [Related]
33. Strategies for discontinuation of proton pump inhibitors: a systematic review. Haastrup P; Paulsen MS; Begtrup LM; Hansen JM; Jarbøl DE Fam Pract; 2014 Dec; 31(6):625-30. PubMed ID: 25192903 [TBL] [Abstract][Full Text] [Related]
34. Value of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in predicting the proton pump inhibitor response in coronary artery disease patients with gastroesophageal reflux-related chest pain. He S; Liu Y; Chen Y; Tang Y; Xu J; Tang C Dis Esophagus; 2016 May; 29(4):367-76. PubMed ID: 25721424 [TBL] [Abstract][Full Text] [Related]
35. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe. Al-Aly Z; Maddukuri G; Xie Y Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235 [TBL] [Abstract][Full Text] [Related]
36. Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project. Calvo LLJ; García Cámara P; Llorente Barrio M; Sierra Gabarda O; Monzón Baez R; Arbonés Mainar JM; Alcedo González J; Bernal Monterde V Eur J Clin Pharmacol; 2021 Dec; 77(12):1927-1933. PubMed ID: 34269841 [TBL] [Abstract][Full Text] [Related]
37. Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design. Shakhnovich V; Ward RM; Kearns GL Clin Pharmacol Ther; 2012 Sep; 92(3):388-92. PubMed ID: 22805424 [TBL] [Abstract][Full Text] [Related]
38. [Summary of the Dutch College of General Practitioners' (NHG) practice guideline 'Gastric symptoms']. de Jongh E; Numans ME; de Wit NJ; Heemstra-Borst CG; Geijer RM; Burgers JS Ned Tijdschr Geneeskd; 2013; 157(22):A6101. PubMed ID: 23714296 [TBL] [Abstract][Full Text] [Related]
39. National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012). Blank ML; Parkin L J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):179-184. PubMed ID: 28403034 [TBL] [Abstract][Full Text] [Related]
40. Objective testing is useful to support PPI deprescribing. Beales ILP BMJ; 2022 Nov; 379():o2812. PubMed ID: 36418049 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]